Dear Friend,

In these times of elections, climate chaos and COVID-19, independent news is more important than ever. You turn to Democracy Now! because you trust that when we're reporting on the pandemic or the uprisings against police brutality—or the climate crisis—our coverage is not brought to you by the fossil fuel, insurance or weapons industries or Big Pharma. We count on YOU to make our work possible. Today, a generous supporter will DOUBLE your new monthly donation to Democracy Now!, meaning your gift will go twice as far. This is a challenging time for us all, but if you're able to make a monthly donation and provide us with support we can rely on all year, please do so today. Stay safe, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Concerns Mount over Politicization of COVID-19 Vaccine, as Trump Lashes Out at “Pathetic” Dr. Birx

HeadlineAug 04, 2020

The U.S. death toll from COVID-19 has topped 156,000 — by far the highest in the world. On Monday, President Trump lashed out at his top White House coronavirus adviser, Dr. Deborah Birx, after she warned the virus is “extraordinarily widespread.” Trump took to Twitter calling Birx “pathetic.”

Meanwhile, concern is growing that the Trump administration may rush to approve a vaccine to boost the president’s chances of winning in November. The New York Times reveals the Department of Health and Human Services produced a slideshow for the White House in April about developing a vaccine. The first slide read, ”DEADLINE: Enable broad access to the public by October 2020.” The date was in bold letters. One regular participant in White House meetings on vaccine development has been Trump’s son-in-law Jared Kushner, who is also helping to run his reelection campaign.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation